Bain Capital Private Equity’s acquisition of DSM Sinochem Pharmaceuticals

Clifford Chance has advised Royal DSM (“DSM”) and Sinochem Group on the disposal of their 50/50 joint venture DSM Sinochem Pharmaceuticals (“DSP”), the global leader in…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Michael Patrini

This content is for Standard 1 Year members only.
Login Join Now